• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】12537

【品名】(6R)-6-[(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,1,1-trifluoro-2-(trifluoromethyl)-2-heptanol

【CA登记号】

【 分 子 式 】C33H50F6O3

【 分 子 量 】608.7486192

【元素组成】C 65.11% H 8.28% F 18.73% O 7.88%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(III)

Falecalcitriol can be obtained by several different ways: 1) The reaction of 24-(tosyloxy)chol-5-en-3beta-ol tetrahydropyranyl ether (I) with LiBr gives the corresponding 24-bromo derivative (II), which is treated with activated Mg (to yield the Grignard reagent) and hexafluoroacetone affording 26,26,26,27,27,27-hexafluoro-3beta-(tetrahydropyranyloxy)cholest-5-en-25-ol (III). The hydrolysis of (III) with p-toluenesulfonic acid gives the diol (V), which is oxidized with dichlorodicyanobenzoquinone (DDQ) in hot dioxane yielding the hexafluoro-25-hydroxycholest-1,4,6-trien-3-one (VI). The epoxidation of (VI) with H2O2 and NaOH in methanol/THF affords the 1alpha,2alpha-epoxide (VII), which is reduced with Li in liquid ammonia to give the hexafluorocholest-5-en-1alpha,3beta,25-triol (VIII). The acetylation of (VIII) with acetic anhydride and dimethylaminopyridine (DMAP) yields the corresponding triacetate (IX), which is treated with N-bromosuccinimide (NBS) and collidine (2,4,6-trimethylpyridine) to afford the hexafluoro-1alpha,3beta,25-triacetoxycholest-5,7-diene (X). The U.V. irradiation of (X) with a medium pressure mercury lamp in benzene/ethanol gives the triacetylated vitamin D3 derivative (XI), which is finally deacetylated with KOH in methanol/THF. 2) An alternative synthesis of the intermediate 26,26,26,27,27,27-hexafluoro-3beta-(tetrahydropyranyloxy)cholest-5-en-25-ol (III) is the reaction of the previously obtained bromo derivative (II) with sodium benzenesulfinate in DMF yielding the sulfone (IV), which is then condensed with hexafluoroacetone by means of lithium diisopropylamide (LDA) in THF.

1 Kobayashi, Y.; Taguchi, T.; Kanuma, N.; Synthesis of 26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3. J Chem Soc Chem Commun 1980, 459-460.
2 Graul, A.; Castaner, J.; Falecalcitriol. Drugs Fut 1997, 22, 5, 473.
3 Kobayashi, Y.; Taguchi, T.; Mitsuhashi, S.; Eguchi, T.; Ohshima, E.; Ikekawa, N.; Studies on organic fluorine compounds. XXXIX. Studies on steroids. LXXIX. Synthesis of 1alpha,25-dihydroxy-26,26,26,27,27,27-hexafluorovitamin D3. Chem Pharm Bull 1982, 30, 12, 4297-4303.
4 DeLuca, H.F.; Tanaka, Y.; Ikekawa, M.; Kobayashi, Y. (Wisconsin Alumni Research Foundation); 26,26,26,27,27,27-Hexafluoro-1alpha,25-dihydroxycholecalciferol and process for preparing the same. JP 1994025280; US 4358406 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12535 (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentyl 4-methylbenzenesulfonate C37H56O5S 详情 详情
(II) 12536 [(3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-4-Bromo-1-methylbutyl]-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]methyl tetrahydro-2H-pyran-2-yl ether C30H49BrO2 详情 详情
(III) 12537 (6R)-6-[(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,1,1-trifluoro-2-(trifluoromethyl)-2-heptanol C33H50F6O3 详情 详情
(IV) 12538 2-([(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(1R)-1-methyl-4-(phenylsulfonyl)butyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]methoxy)tetrahydro-2H-pyran; (4R)-4-[(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentyl phenyl sulfone C36H54O4S 详情 详情
(V) 12539 (3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(1R)-6,6,6-trifluoro-5-hydroxy-1-methyl-5-(trifluoromethyl)hexyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H40F6O2 详情 详情
(VI) 12540 (8S,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-[(1R)-6,6,6-trifluoro-5-hydroxy-1-methyl-5-(trifluoromethyl)hexyl]-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one C27H34F6O2 详情 详情
(VII) 12541 (2aR,3aR,3bR,3cS,5aR,6R,8aS,8bS)-3b,5a-Dimethyl-6-[(1R)-6,6,6-trifluoro-5-hydroxy-1-methyl-5-(trifluoromethyl)hexyl]-2a,3a,3b,3c,4,5,5a,6,7,8,8a,8b-dodecahydro-2H-cyclopenta[7,8]phenanthro[3,4-b]oxiren-2-one C27H34F6O3 详情 详情
(VIII) 12542 (1S,3R,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(1R)-6,6,6-trifluoro-5-hydroxy-1-methyl-5-(trifluoromethyl)hexyl]-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-1,3-diol C27H40F6O3 详情 详情
(IX) 12543 (1S,3R,8S,9S,10R,13R,14S,17R)-1-(acetoxy)-17-[(1R)-5-(acetoxy)-6,6,6-trifluoro-1-methyl-5-(trifluoromethyl)hexyl]-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate C33H46F6O6 详情 详情
(X) 12544 (1S,3R,9S,10R,13R,14R,17R)-1-(acetoxy)-17-[(1R)-5-(acetoxy)-6,6,6-trifluoro-1-methyl-5-(trifluoromethyl)hexyl]-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate C33H44F6O6 详情 详情
(XI) 12545 (1R,5S)-3-((Z)-2-[(1R,3aR,7aR)-1-[(1R)-5-(acetoxy)-6,6,6-trifluoro-1-methyl-5-(trifluoromethyl)hexyl]-7a-methyloctahydro-4H-inden-4-ylidene]ethylidene)-5-(acetoxy)-4-methylenecyclohexyl acetate C33H44F6O6 详情 详情
Extended Information